2021-08-06
|
R-HSA-9759774
|
Diseases of mitochondrial beta oxidation
|
BibTex
|
2021-07-09
|
R-HSA-9735804
|
Diseases of nucleotide metabolism
|
BibTex
|
2021-07-09
|
R-HSA-9735786
|
Nucleotide catabolism defects
|
BibTex
|
2021-07-09
|
R-HSA-9735763
|
Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine
|
BibTex
|
2021-07-09
|
R-HSA-9734207
|
Nucleotide salvage defects
|
BibTex
|
2021-07-09
|
R-HSA-9734281
|
Defective HPRT1 disrupts guanine and hypoxanthine salvage
|
BibTex
|
2021-07-09
|
R-HSA-9734735
|
Defective ADA disrupts (deoxy)adenosine deamination
|
BibTex
|
2021-07-09
|
R-HSA-9734195
|
Defective APRT disrupts adenine salvage
|
BibTex
|
2020-01-09
|
R-HSA-9673163
|
Oleoyl-phe metabolism
|
BibTex
|
2019-07-15
|
R-HSA-916853
|
Degradation of GABA
|
BibTex
|
2017-01-19
|
R-HSA-8955332
|
Carboxyterminal post-translational modifications of tubulin
|
BibTex
|
2016-08-04
|
R-HSA-8964038
|
LDL clearance
|
BibTex
|
2016-02-18
|
R-HSA-8964011
|
HDL clearance
|
BibTex
|
2016-01-29
|
R-HSA-8848584
|
Wax and plasmalogen biosynthesis
|
BibTex
|
2016-01-27
|
R-HSA-174824
|
Plasma lipoprotein assembly, remodeling, and clearance
|
BibTex
|
2016-01-27
|
R-HSA-8964043
|
Plasma lipoprotein clearance
|
BibTex
|
2016-01-27
|
R-HSA-8964026
|
Chylomicron clearance
|
BibTex
|
2016-01-27
|
R-HSA-8963899
|
Plasma lipoprotein remodeling
|
BibTex
|
2016-01-27
|
R-HSA-8963901
|
Chylomicron remodeling
|
BibTex
|
2016-01-27
|
R-HSA-8963898
|
Plasma lipoprotein assembly
|
BibTex
|
2016-01-27
|
R-HSA-8963888
|
Chylomicron assembly
|
BibTex
|
2015-11-30
|
R-HSA-6814848
|
Glycerophospholipid catabolism
|
BibTex
|
2015-11-02
|
R-HSA-8957322
|
Metabolism of steroids
|
BibTex
|
2015-11-02
|
R-HSA-191273
|
Cholesterol biosynthesis
|
BibTex
|
2015-11-02
|
R-HSA-6807062
|
Cholesterol biosynthesis via lathosterol
|
BibTex
|
2015-11-02
|
R-HSA-6807047
|
Cholesterol biosynthesis via desmosterol
|
BibTex
|
2015-11-02
|
R-HSA-6806667
|
Metabolism of fat-soluble vitamins
|
BibTex
|
2015-11-02
|
R-HSA-6806664
|
Metabolism of vitamin K
|
BibTex
|
2015-08-18
|
R-HSA-6791465
|
Pentose phosphate pathway disease
|
BibTex
|
2015-08-18
|
R-HSA-5659996
|
RPIA deficiency: failed conversion of R5P to RU5P
|
BibTex
|
2015-08-18
|
R-HSA-6791055
|
TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P
|
BibTex
|
2015-08-18
|
R-HSA-6791461
|
RPIA deficiency: failed conversion of RU5P to R5P
|
BibTex
|
2015-08-18
|
R-HSA-6791462
|
TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P
|
BibTex
|
2015-08-18
|
R-HSA-5662853
|
Essential pentosuria
|
BibTex
|
2015-08-17
|
R-HSA-3229121
|
Glycogen storage diseases
|
BibTex
|
2015-08-17
|
R-HSA-3814836
|
Glycogen storage disease type XV (GYG1)
|
BibTex
|
2015-08-17
|
R-HSA-3858516
|
Glycogen storage disease type 0 (liver GYS2)
|
BibTex
|
2015-08-17
|
R-HSA-3229133
|
Glycogen storage disease type Ib (SLC37A4)
|
BibTex
|
2015-08-17
|
R-HSA-3282872
|
Severe congenital neutropenia type 4 (G6PC3)
|
BibTex
|
2015-08-17
|
R-HSA-5357609
|
Glycogen storage disease type II (GAA)
|
BibTex
|
2015-08-17
|
R-HSA-3878781
|
Glycogen storage disease type IV (GBE1)
|
BibTex
|
2015-08-17
|
R-HSA-3828062
|
Glycogen storage disease type 0 (muscle GYS1)
|
BibTex
|
2015-08-17
|
R-HSA-3274531
|
Glycogen storage disease type Ia (G6PC)
|
BibTex
|
2015-08-14
|
R-HSA-5661270
|
Formation of xylulose-5-phosphate
|
BibTex
|
2015-01-29
|
R-HSA-5657560
|
Hereditary fructose intolerance
|
BibTex
|
2015-01-29
|
R-HSA-5659898
|
Intestinal saccharidase deficiencies
|
BibTex
|
2015-01-29
|
R-HSA-5657562
|
Essential fructosuria
|
BibTex
|
2015-01-29
|
R-HSA-5653890
|
Lactose synthesis
|
BibTex
|
2015-01-29
|
R-HSA-70350
|
Fructose catabolism
|
BibTex
|
2015-01-29
|
R-HSA-5652227
|
Fructose biosynthesis
|
BibTex
|
2013-07-26
|
R-HSA-8982491
|
Glycogen metabolism
|
BibTex
|
2013-07-26
|
R-HSA-3322077
|
Glycogen synthesis
|
BibTex
|
2012-05-16
|
R-HSA-1475029
|
Reversible hydration of carbon dioxide
|
BibTex
|
2012-04-27
|
R-HSA-1480926
|
O2/CO2 exchange in erythrocytes
|
BibTex
|
2012-04-27
|
R-HSA-1247673
|
Erythrocytes take up oxygen and release carbon dioxide
|
BibTex
|
2012-04-27
|
R-HSA-1237044
|
Erythrocytes take up carbon dioxide and release oxygen
|
BibTex
|
2012-03-16
|
R-HSA-2160456
|
Phenylketonuria
|
BibTex
|
2012-03-16
|
R-HSA-2161522
|
Abacavir ADME
|
BibTex
|
2012-03-16
|
R-HSA-2161517
|
Abacavir transmembrane transport
|
BibTex
|
2012-03-16
|
R-HSA-2161541
|
Abacavir metabolism
|
BibTex
|
2010-11-09
|
R-HSA-2978092
|
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate
|
BibTex
|
2010-11-09
|
R-HSA-880009
|
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate
|
BibTex
|
2010-09-23
|
R-HSA-1296071
|
Potassium Channels
|
BibTex
|
2010-09-23
|
R-HSA-1296061
|
HCN channels
|
BibTex
|
2010-09-23
|
R-HSA-1296072
|
Voltage gated Potassium channels
|
BibTex
|
2010-09-23
|
R-HSA-1296346
|
Tandem pore domain potassium channels
|
BibTex
|
2010-09-23
|
R-HSA-1299308
|
Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)
|
BibTex
|
2010-09-23
|
R-HSA-1299503
|
TWIK related potassium channel (TREK)
|
BibTex
|
2010-09-23
|
R-HSA-1299316
|
TWIK-releated acid-sensitive K+ channel (TASK)
|
BibTex
|
2010-09-23
|
R-HSA-1299287
|
Tandem pore domain halothane-inhibited K+ channel (THIK)
|
BibTex
|
2010-09-23
|
R-HSA-1299344
|
TWIK-related spinal cord K+ channel (TRESK)
|
BibTex
|
2010-09-23
|
R-HSA-1299361
|
TWIK-related alkaline pH activated K+ channel (TALK)
|
BibTex
|
2010-09-23
|
R-HSA-1296052
|
Ca2+ activated K+ channels
|
BibTex
|
2010-09-23
|
R-HSA-1296065
|
Inwardly rectifying K+ channels
|
BibTex
|
2010-09-23
|
R-HSA-1296025
|
ATP sensitive Potassium channels
|
BibTex
|
2010-09-23
|
R-HSA-1296059
|
G protein gated Potassium channels
|
BibTex
|
2010-09-23
|
R-HSA-1296041
|
Activation of G protein gated Potassium channels
|
BibTex
|
2010-09-23
|
R-HSA-1296053
|
Classical Kir channels
|
BibTex
|
2010-09-23
|
R-HSA-1296067
|
Potassium transport channels
|
BibTex
|
2009-08-21
|
R-HSA-428157
|
Sphingolipid metabolism
|
BibTex
|
2009-03-03
|
R-HSA-389661
|
Glyoxylate metabolism and glycine degradation
|
BibTex
|
2009-02-27
|
R-HSA-75896
|
Plasmalogen biosynthesis
|
BibTex
|
2009-02-27
|
R-HSA-8978934
|
Metabolism of cofactors
|
BibTex
|
2009-02-27
|
R-HSA-390918
|
Peroxisomal lipid metabolism
|
BibTex
|
2009-02-27
|
R-HSA-389887
|
Beta-oxidation of pristanoyl-CoA
|
BibTex
|
2009-02-27
|
R-HSA-389599
|
Alpha-oxidation of phytanate
|
BibTex
|
2009-02-27
|
R-HSA-390247
|
Beta-oxidation of very long chain fatty acids
|
BibTex
|
2009-02-27
|
R-HSA-389542
|
NADPH regeneration
|
BibTex
|
2008-12-02
|
R-HSA-382551
|
Transport of small molecules
|
BibTex
|
2008-06-13
|
R-HSA-8963676
|
Intestinal absorption
|
BibTex
|
2008-06-13
|
R-HSA-8963678
|
Intestinal lipid absorption
|
BibTex
|
2008-06-13
|
R-HSA-8964058
|
HDL remodeling
|
BibTex
|
2008-06-13
|
R-HSA-8964041
|
LDL remodeling
|
BibTex
|
2008-06-13
|
R-HSA-8963896
|
HDL assembly
|
BibTex
|
2008-06-03
|
R-HSA-352230
|
Amino acid transport across the plasma membrane
|
BibTex
|
2008-01-28
|
R-HSA-204626
|
Hypusine synthesis from eIF5A-lysine
|
BibTex
|
2007-02-03
|
R-HSA-8978868
|
Fatty acid metabolism
|
BibTex
|
2007-02-03
|
R-HSA-8979227
|
Triglyceride metabolism
|
BibTex
|
2007-02-03
|
R-HSA-163560
|
Triglyceride catabolism
|
BibTex
|
2007-02-03
|
R-HSA-75109
|
Triglyceride biosynthesis
|
BibTex
|
2005-06-14
|
R-DME-5252538
|
Drosophila signaling pathways
|
BibTex
|